109 related articles for article (PubMed ID: 7398137)
1. Tissue distribution of orally administered bismuth in the rat.
Lee SP; Lim TH; Pybus J; Clarke AC
Clin Exp Pharmacol Physiol; 1980; 7(3):319-24. PubMed ID: 7398137
[TBL] [Abstract][Full Text] [Related]
2. Brain and blood levels of bismuth after oral or parenteral administration of tripotassium-dicitrato bismuthate to rats.
Abbracchio MP; Balduini W; Cavallaro A; Adamoli P; Fittipaldi M; Muzio F; Malandrino S; Cattabeni F
Neurotoxicology; 1985; 6(3):139-43. PubMed ID: 4047510
[TBL] [Abstract][Full Text] [Related]
3. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.
Gavey CJ; Szeto ML; Nwokolo CU; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 1989 Feb; 3(1):21-8. PubMed ID: 2491455
[TBL] [Abstract][Full Text] [Related]
4. Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal function.
Treiber G; Gladziwa U; Ittel TH; Walker S; Schweinsberg F; Klotz U
Aliment Pharmacol Ther; 1991 Oct; 5(5):491-502. PubMed ID: 1793780
[TBL] [Abstract][Full Text] [Related]
5. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
Koo J; Ho J; Lam SK; Wong J; Ong GB
Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
[TBL] [Abstract][Full Text] [Related]
6. Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.
Lee SP
Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):359-64. PubMed ID: 7335960
[TBL] [Abstract][Full Text] [Related]
7. Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate.
Madaus S; Schulte-Frohlinde E; Scherer C; Kämmereit A; Schusdziarra V; Classen M
Aliment Pharmacol Ther; 1992 Apr; 6(2):241-9. PubMed ID: 1288519
[TBL] [Abstract][Full Text] [Related]
8. [Tissue binding of orally administered bismuth in the rat. Effect of the digestive microbial flora].
Jeanrot R; Chaleil D; Allain P; Papillon C; Raynaud G; Bouvet P
Toxicol Eur Res; 1982 Jul; 4(4):181-5. PubMed ID: 7157361
[TBL] [Abstract][Full Text] [Related]
9. Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.
Froomes PR; Wan AT; Keech AC; McNeil JJ; McLean AJ
Eur J Clin Pharmacol; 1989; 37(5):533-6. PubMed ID: 2598996
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate.
Treiber G; Walker S; Klotz U
Clin Pharmacol Ther; 1994 May; 55(5):486-91. PubMed ID: 8181192
[TBL] [Abstract][Full Text] [Related]
11. The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate.
Nwokolo CU; Gavey CJ; Smith JT; Pounder RE
Aliment Pharmacol Ther; 1989 Feb; 3(1):29-39. PubMed ID: 2491456
[TBL] [Abstract][Full Text] [Related]
12. Bismuth concentration in blood and urine of children treated with ventrisol (polfa) preliminary study.
Iwańczak F; Rajska H; Iwańczak B; Górecka H
Rocz Akad Med Bialymst; 1995; 40(3):685-91. PubMed ID: 8775327
[TBL] [Abstract][Full Text] [Related]
13. Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure.
Playford RJ; Matthews CH; Campbell MJ; Delves HT; Hla KK; Hodgson HJ; Calam J
Gut; 1990 Mar; 31(3):359-60. PubMed ID: 2323603
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence of neurotoxicity following 8 weeks of treatment with tripotassium dicitrato bismuthate.
Nwokolo CU; Fitzpatrick JD; Paul R; Dyal R; Smits BJ; Loft DE
Aliment Pharmacol Ther; 1994 Feb; 8(1):45-53. PubMed ID: 8186346
[TBL] [Abstract][Full Text] [Related]
15. The ultrastructural localisation of De-Nol (colloidal tripotassium dicitrato-bismuthate--TDB) in the upper gastrointestinal tract of man and rodents following oral and instrumental administration.
Coghill SB; Hopwood D; McPherson S; Hislop S
J Pathol; 1983 Feb; 139(2):105-14. PubMed ID: 6827397
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
Lacey LF; Frazer NM; Keene ON; Smith JT
Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
[TBL] [Abstract][Full Text] [Related]
17. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
Hamilton I; Worsley BW; O'Connor HJ; Axon AT
Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
[TBL] [Abstract][Full Text] [Related]
18. [Kidney uptake of bismuth as an index of its digestive absorption in mice].
Renault H; Rapin JR; Bralet AM
C R Acad Hebd Seances Acad Sci D; 1976 Jan; 282(3):325-7. PubMed ID: 816560
[TBL] [Abstract][Full Text] [Related]
19. Chelation of bismuth by combining desferrioxamine and deferiprone in rats.
Tubafard S; Fatemi SJ
Toxicol Ind Health; 2008 May; 24(4):235-40. PubMed ID: 19022876
[TBL] [Abstract][Full Text] [Related]
20. Effect of selenium on the organ distribution and binding of bismuth in rat tissues.
Szymańska JA; Zychowicz M; Zelazowski AJ; Piotrowski JK
Arch Toxicol; 1978 Apr; 40(2):131-41. PubMed ID: 580734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
